Publications by authors named "Sho Horikoshi"

Claim this Profile
R
Real-World Effectiveness and Safety of Daridorexant in Japanese Patients With Insomnia: A Multicenter Observational Study Evaluating Four-Week Changes in Athens Insomnia Scale Among 54 Participants.
Soichi Kono, Tasuku Nishiyama, Saki Nakano, Yoshikazu Ishimoto, Sho Horikoshi

Cureus· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Validity of the 5-Factor PANSS Model in Acute Schizophrenia: Early Response to Aripiprazole and Brexpiprazole.
Yuri Kobayashi, Mizue Ichinose, Toshihiro Terui, Hiroshi Hoshino, Yuhei Suzuki, Sho Horikoshi

J Clin Psychopharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial central diabetes insipidus during lithium use: A case report and literature review.
Mizue Ichinose, Yuri Kobayashi, Yuhei Suzuki, Yoichiro Hirata, Masayuki Goto, Sho Horikoshi

PCN Rep· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Effectiveness and Tolerability of Lurasidone in Outpatients with Bipolar DisorderII- A 24 week retrospective study (RETLO-BDIIstudy).
Sho Horikoshi, Yuhei Suzuki, Yuri Kobayashi, Yoichiro Hirata, Mizue Ichinose

J Affect Disord· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with cognitive dysfunction in treatment-responsive and -resistant schizophrenia: A pilot cross-sectional study.
Yuhei Suzuki, Kenya Watanabe, Keiko Kanno-Nozaki, Sho Horikoshi, Mizue Ichinose

J Psychiatr Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching to lemborexant for the management of insomnia in mental disorders: the SLIM study.
Sho Horikoshi, Itaru Miura, Yuhei Suzuki, Yuri Kobayashi, Yoichiro Hirata

J Clin Sleep Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy.
Itaru Miura, Sho Horikoshi, Mizue Ichinose, Yuhei Suzuki, Kenya Watanabe

Drug Des Devel Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-Generation Antipsychotic Long-Acting Injection Reduced the Time of Restrictive Interventions in Patients With Schizophrenia: Retrospective, A 4-Year Mirror-Image Study.
Sho Horikoshi, Itaru Miura, Akihiro Mui, Takeshi Hikichi, Tetsuro Aono

J Clin Psychopharmacol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of benzodiazepine and orexin receptor antagonist on cognitive function revealed by auditory event-related potentials.
Tetsuya Shiga, Hiroshi Hoshino, Haruka Ochiai, Yusuke Osakabe, Kazuko Kanno, Sho Horikoshi

J Psychopharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memantine for Behavioral Symptoms of Hepatic Encephalopathy Associated With Alcoholic Cirrhosis: A Case Report.
Mizue Ichinose, Itaru Miura, Sho Horikoshi, Junya Matsumoto, Yusuke Osakabe

J Clin Psychopharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of oxytocin nasal spray on auditory automatic discrimination measured by mismatch negativity.
Haruka Ochiai, Tetsuya Shiga, Hiroshi Hoshino, Sho Horikoshi, Kazuko Kanno

Psychopharmacology (Berl)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder.
Mizue Ichinose, Itaru Miura, Sho Horikoshi, Shinnosuke Yamamoto, Keiko Kanno-Nozaki

Neuropsychiatr Dis Treat· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Treatment Response With Antidementia Drugs After 6 Months in Alzheimer's Disease Predict Long-term Treatment Outcome?
Sho Horikoshi, Yasuto Kunii, Junya Matsumoto, Daisuke Gotoh, Itaru Miura

J Clin Psychopharmacol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma levels of dopamine metabolite correlate with mismatch negativity in patients with schizophrenia.
Tetsuya Shiga, Sho Horikoshi, Kazuko Kanno, Keiko Kanno-Nozaki, Masayuki Hikita

Psychiatry Clin Neurosci· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Young patient with treatment-resistant schizophrenia drastically improved by combination of clozapine and maintenance electroconvulsive therapy: a case report.
Masashi Ito, Yasuto Kunii, Sho Horikoshi, Itaru Miura, Shuntaro Itagaki

Int Med Case Rep J· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low- and high-dose aripiprazole augmentation and plasma levels of homovanillic acid in major depressive disorder: A randomized, open-label study.
Sho Horikoshi, Itaru Miura, Mizue Ichinose, Shinnosuke Yamamoto, Masashi Ito

Hum Psychopharmacol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Relationship between Mismatch Negativity and the COMTVal108/158Met Genotype in Schizophrenia.
Sho Horikoshi, Tetsuya Shiga, Hiroshi Hoshino, Haruka Ochiai, Keiko Kanno-Nozaki

Neuropsychobiology· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influences of the T102C polymorphism in the 5-HT2A receptor gene on the five-factor model of Positive and Negative Syndrome Scale and treatment response to aripiprazole in patients with acute schizophrenia.
Keiko Kanno-Nozaki, Itaru Miura, Haruka Kaneko, Sho Horikoshi, Takafumi Ota

Psychiatry Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Val 108/158 Met polymorphism and treatment response to aripiprazole in patients with acute schizophrenia.
Haruka Kaneko, Itaru Miura, Keiko Kanno-Nozaki, Sho Horikoshi, Mizuki Hino

Neuropsychiatr Dis Treat· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation of ANKK1 and response to aripiprazole in patients with acute schizophrenia: A preliminary study.
Itaru Miura, Yasuto Kunii, Mizuki Hino, Hiroshi Hoshino, Junya Matsumoto, Sho Horikoshi

J Psychiatr Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hashimoto encephalopathy with high plasma monoamine metabolite levels: a case report.
Sho Horikoshi, Itaru Miura, Yasuto Kunii, Satoko Asano, Keiko Kanno-Nozaki

Neuropsychiatr Dis Treat· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between five-factor model of the Positive and Negative Syndrome Scale and plasma levels of monoamine metabolite in patients with schizophrenia.
Kenya Watanabe, Itaru Miura, Keiko Kanno-Nozaki, Sho Horikoshi, Hirobumi Mashiko

Psychiatry Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Shakuyaku-Kanzo-to on Extrapyramidal Symptoms During Antipsychotic Treatment: A Randomized, Open-Label Study.
Takafumi Ota, Itaru Miura, Keiko Kanno-Nozaki, Hiroshi Hoshino, Sho Horikoshi

J Clin Psychopharmacol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of -141C Ins/Del Polymorphism in DRD2 Gene on Clinical Symptoms and Plasma Homovanillic Acid Levels in the Treatment of Schizophrenia With Aripiprazole.
Itaru Miura, Keiko Kanno-Nozaki, Mizuki Hino, Sho Horikoshi, Takafumi Ota

J Clin Psychopharmacol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis